Lisa Von Moltke is of Seres Therapeutics, Inc.. Currently has a direct ownership of 21,013 shares of MCRB, which is worth approximately $17,440. The most recent transaction as insider was on Aug 16, 2024, when has been sold 973 shares (Common Stock) at a price of $0.84 per share, resulting in proceeds of $817. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 21K
10.5% 3M change
n/a 12M change
Total Value Held $17,440

Lisa von Moltke Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 16 2024
SELL
Open market or private sale
$817 $0.84 p/Share
973 Reduced 4.43%
21,013 Common Stock
Aug 15 2024
BUY
Exercise of conversion of derivative security
-
2,969 Added 11.9%
21,986 Common Stock
May 15 2024
SELL
Open market or private sale
$882 $0.94 p/Share
939 Reduced 4.71%
19,017 Common Stock
May 15 2024
BUY
Exercise of conversion of derivative security
-
2,968 Added 12.95%
19,956 Common Stock
Feb 16 2024
SELL
Open market or private sale
$4,752 $1.08 p/Share
4,400 Reduced 20.57%
16,988 Common Stock
Feb 15 2024
BUY
Exercise of conversion of derivative security
-
11,875 Added 35.7%
21,388 Common Stock
Oct 30 2023
SELL
Open market or private sale
$5,713 $1.35 p/Share
4,232 Reduced 30.79%
9,513 Common Stock
Oct 27 2023
BUY
Exercise of conversion of derivative security
-
13,745 Added 50.0%
13,745 Common Stock

Also insider at

CARA
Cara Therapeutics, Inc. Healthcare
LvM

Lisa Von Moltke

Cambridge, MA

Track Institutional and Insider Activities on MCRB

Follow Seres Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MCRB shares.

Notify only if

Insider Trading

Get notified when an Seres Therapeutics, Inc. insider buys or sells MCRB shares.

Notify only if

News

Receive news related to Seres Therapeutics, Inc.

Track Activities on MCRB